ALPHAMAB-B (09966) grants a total of 300,000 award shares
ALPHAMAB-B (09966) announced that on October 27, 2026, pursuant to the restricted share award scheme, the Company resolved to grant a total of 300,000 award shares to one eligible participant (who is an employee of the Group), entitling the grantee to subscribe for up to a total of 300,000 ordinary shares of the Company with a par value of US$0.000002 each, subject to acceptance by the award grantee.
ALPHAMAB-B (09966) announced that on October 27, 2026, pursuant to the restricted share award scheme, the company resolved to grant a total of 300,000 award shares to one eligible participant (who is an employee of the group), entitling the grantee to subscribe for up to a total of 300,000 ordinary shares of the company with a par value of US$0.000002 each, subject to acceptance by the award grantee.
Related Articles
JIANGXI COPPER (00358) reported a net profit attributable to shareholders of RMB11.687 billion for the first three quarters, up 94.02% year on year.
GPIXEL (03277): Wu Qinyun Appointed as Joint Company Secretary and Authorized Representative
IMMUNEONCO-B (01541) proposes to appoint Zhonghui as auditor
JIANGXI COPPER (00358) reported a net profit attributable to shareholders of RMB11.687 billion for the first three quarters, up 94.02% year on year.
GPIXEL (03277): Wu Qinyun Appointed as Joint Company Secretary and Authorized Representative
IMMUNEONCO-B (01541) proposes to appoint Zhonghui as auditor
